Janux Therapeutics JANX
NASDAQ JANX
$17.06 +0.13 (+0.77%)
At close: Oct 22, 2026 · 4:00 PM EDT

Janux Therapeutics (JANX) Ending Cash Balance (2020 - 2021)

Updated

Analysis

Janux Therapeutics (JANX) Ending Cash Balance (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.57 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.03 Bn
10 Janux Therapeutics 1.07 Bn -2.81 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 39.39 Mn
Jun 30, 2021 251.63 Mn
Dec 31, 2020 7.81 Mn
Sep 30, 2020 4.89 Mn
Jun 30, 2020 6.01 Mn
API Access

Janux Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=JANX&period=max&api_key=YOUR_API_KEY